Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer

por Santiago-Sánchez, Ginette S., Pita-Grisanti, Valentina, Quiñones-Díaz, Blanca, Gumpper, Kristyn, Cruz-Monserrate, Zobeida, Vivas-Mejía, Pablo E.
Publicado 2020

MicroRNA-18a-5p Suppresses Tumor Growth via Targeting Matrix Metalloproteinase-3 in Cisplatin-Resistant Ovarian Cancer

por Quiñones-Díaz, Blanca I., Reyes-González, Jeyshka M., Sánchez-Guzmán, Victoria, Conde-Del Moral, Isabel, Valiyeva, Fatma, Santiago-Sánchez, Ginette S., Vivas-Mejía, Pablo E.
Publicado 2020

Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors

por Santiago-Sánchez, Ginette S., Noriega-Rivera, Ricardo, Hernández-O’Farrill, Eliud, Valiyeva, Fatma, Quiñones-Diaz, Blanca, Villodre, Emilly S., Debeb, Bisrat G., Rosado-Albacarys, Andrea, Vivas-Mejía, Pablo E.
Publicado 2021

Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer

por Reyes-González, Jeyshka M., Quiñones-Díaz, Blanca I., Santana, Yasmarie, Báez-Vega, Perla M., Soto, Daniel, Valiyeva, Fatima, Marcos-Martínez, María J., Fernández-de Thomas, Ricardo J., Vivas-Mejía, Pablo E.
Publicado 2020

Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma

por Grafals-Ruiz, Nilmary, Rios-Vicil, Christian I, Lozada-Delgado, Eunice L, Quiñones-Díaz, Blanca I, Noriega-Rivera, Ricardo A, Martínez-Zayas, Gabriel, Santana-Rivera, Yasmarie, Santiago-Sánchez, Ginette S, Valiyeva, Fatma, Vivas-Mejía, Pablo E
Publicado 2020

Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells

por Rabelo-Fernández, Robert J., Santiago-Sánchez, Ginette S., Sharma, Rohit K., Roche-Lima, Abiel, Carrion, Kelvin Carrasquillo, Rivera, Ricardo A. Noriega, Quiñones-Díaz, Blanca I., Rajasekaran, Swetha, Siddiqui, Jalal, Miles, Wayne, Rivera, Yasmarie Santana, Valiyeva, Fatima, Vivas-Mejia, Pablo E.
Publicado 2022